Sigyn Therapeutics Sells Shares for $100
Ticker: SIGY · Form: 8-K · Filed: Oct 7, 2024 · CIK: 1642159
| Field | Detail |
|---|---|
| Company | Sigyn Therapeutics, Inc. (SIGY) |
| Form Type | 8-K |
| Filed Date | Oct 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $474,793, $4.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: unregistered-sale, equity-securities
TL;DR
Sigyn Therapeutics sold 1M shares for $100 on Oct 4.
AI Summary
On October 4, 2024, Sigyn Therapeutics, Inc. reported the unregistered sale of 1,000,000 shares of its common stock at an exercise price of $0.0001 per share. This transaction resulted in gross proceeds of $100 to the company. The shares were issued to a single purchaser.
Why It Matters
This filing details a small, unregistered sale of equity, which may indicate minor financing activities or compensation arrangements for the company.
Risk Assessment
Risk Level: low — The filing concerns a minor unregistered sale of equity with minimal financial impact.
Key Numbers
- 1,000,000 — Shares Sold (Unregistered sale of common stock)
- $100 — Gross Proceeds (From the sale of 1,000,000 shares)
- $0.0001 — Exercise Price (Per share for the unregistered sale)
Key Players & Entities
- Sigyn Therapeutics, Inc. (company) — Registrant
- October 4, 2024 (date) — Date of earliest event reported
- 1,000,000 (share_amount) — Number of shares sold
- $0.0001 (dollar_amount) — Exercise price per share
- $100 (dollar_amount) — Gross proceeds from sale
FAQ
What was the total number of shares sold in the unregistered offering?
The company sold 1,000,000 shares of its common stock.
What was the exercise price per share for these unregistered shares?
The exercise price was $0.0001 per share.
What were the total gross proceeds from this sale?
The gross proceeds from the sale were $100.
When was the earliest event reported in this filing?
The earliest event reported was on September 30, 2024, with the report date being October 4, 2024.
To how many purchasers were these unregistered shares sold?
The shares were sold to a single purchaser.
Filing Stats: 493 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2024-10-04 17:40:06
Key Financial Figures
- $474,793 — through October 4, 2024, the holders of $474,793 of Original Issue Discount Senior Conve
- $4.00 — n average contractual exercise price of $4.00 per share in exchange for the issuance
Filing Documents
- form8-k.htm (8-K) — 35KB
- 0001493152-24-039594.txt ( ) — 201KB
- sigy-20241004.xsd (EX-101.SCH) — 3KB
- sigy-20241004_lab.xml (EX-101.LAB) — 33KB
- sigy-20241004_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SIGYN THERAPEUTICS, INC. Date: October 4, 2024 By: /s/ James A. Joyce James A. Joyce, Chairman and CEO